Oral β-Lactam Antibiotics for Pediatric Otitis Media, Rhinosinusitis, and Pneumonia
Insights
This review examines antibiotic properties for common pediatric infections like pneumonia. It compares the effectiveness of oral beta-lactams against Streptococcus pneumoniae to guide better prescribing practices.
Area of Science:
- Pediatric infectious diseases
- Pharmacology and pharmacokinetics
- Antimicrobial stewardship
Background:
- Acute otitis media, acute bacterial rhinosinusitis, and community-acquired pneumonia are leading causes of antibiotic use in children.
- Prescribing antibiotics for these common pediatric infections presents challenges due to numerous options, antibiotic allergies, and transitioning from intravenous to oral therapy.
- Confusion and errors in prescribing can occur, impacting treatment efficacy and antimicrobial resistance.
Purpose of the Study:
- To evaluate the pharmacokinetic and pharmacodynamic (PK/PD) properties of commonly prescribed antibiotics for pediatric respiratory tract infections.
- To compare the antipneumococcal activity of various oral beta-lactam antibiotics.
- To provide evidence-based guidance for optimizing antibiotic selection in pediatric care.
Main Methods:
- Literature review of pharmacokinetic and pharmacodynamic data for relevant antibiotics.
- Comparative analysis of in vitro and in vivo studies assessing antipneumococcal activity of oral beta-lactams.
- Synthesis of data to inform clinical decision-making.
Main Results:
- Detailed PK/PD profiles of key antibiotics used in pediatric otitis media, rhinosinusitis, and pneumonia were compiled.
- Significant variations in antipneumococcal activity were observed among different oral beta-lactam agents.
- Data highlights the importance of selecting agents with robust activity against Streptococcus pneumoniae.
Conclusions:
- Understanding antibiotic PK/PD properties is crucial for effective treatment of common pediatric infections.
- Oral beta-lactams exhibit differential activity against Streptococcus pneumoniae, influencing treatment choice.
- Optimized antibiotic selection based on PK/PD and pathogen susceptibility can improve outcomes and support antimicrobial stewardship.
Abstract:
Acute otitis media, acute bacterial rhinosinusitis, and community-acquired pneumonia are major drivers of pediatric antibiotic consumption. With many available options and the added challenges of navigating antibiotic allergies and de-escalating from intravenous treatment for children requiring hospitalization, prescribing for these relatively simple infections can be a source of confusion and error. The purpose of this article is to evaluate the pharmacokinetic and pharmacodynamic properties of antibiotics commonly prescribed for these disease states, and to specifically compare antipneumococcal activity between oral beta-lactams.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Related Concept Videos
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:26Tonsillitis II: Management
01:30Pneumonia III: Complications and Assessment
01:30Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion